medroxyprogesterone acetate has been researched along with Bonnevie-Ullrich Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botsis, D; Creatsas, G; Deligeoroglou, E; Makrakis, E; Papagianni, V | 1 |
| Milki, AA; Tazuke, SI | 1 |
| Burket, RL; Rauh, JL; Waldrop, CD | 1 |
| Fujimaki, T; Kurabayashi, T; Oda, K; Tanaka, K; Yamamoto, Y; Yasuda, M | 1 |
| McCartney, AJ; Williams, K; Woolas, RP | 1 |
| Dvorakova, M; Hampl, R; Hill, M; Lebl, J; Lisa, L; Snajderova, M; Starka, L; Sulcova, J | 1 |
| Baudier, MM; Chihal, HJ; Dickey, RP | 1 |
7 other study(ies) available for medroxyprogesterone acetate and Bonnevie-Ullrich Syndrome
| Article | Year |
|---|---|
Response to hormonal treatment of young females with primary or very premature ovarian failure.
Topics: Adolescent; Amenorrhea; Bone Density; Cholesterol, HDL; Estrogens; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis, 46,XY; Humans; Medroxyprogesterone Acetate; Primary Ovarian Insufficiency; Turner Syndrome; Young Adult | 2011 |
Endometrioma of uterine serosa in a woman with mosaic Turner's syndrome receiving hormone replacement therapy: case report.
Topics: Adult; Endometriosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Mosaicism; Turner Syndrome; Uterine Diseases | 2002 |
Chromosomally competent ovarian failure at adolescence.
Topics: Adolescent; Contraceptives, Oral, Combined; Diagnosis, Differential; Drug Combinations; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis; Humans; Karyotyping; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause, Premature; Menstruation Disturbances; Mestranol; Norethindrone; Norethynodrel; Ovarian Function Tests; Ovary; Turner Syndrome | 1983 |
Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome.
Topics: Absorptiometry, Photon; Adult; Bone Density; Estrogen Replacement Therapy; Female; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Mestranol; Primary Ovarian Insufficiency; T-Lymphocyte Subsets; Turner Syndrome | 1993 |
Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
Topics: Adult; Cystadenocarcinoma, Papillary; Female; Humans; Medroxyprogesterone Acetate; Turner Syndrome; Uterine Neoplasms | 1994 |
Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Adult; Androstenedione; Biomarkers; Child; Child, Preschool; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Female; Human Growth Hormone; Humans; Immunoradiometric Assay; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Progesterone; Sex Hormone-Binding Globulin; Testosterone; Turner Syndrome | 2001 |
Pregnancy and reproductive function in a patient with non-mosaic Turner syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Diethylstilbestrol; Dimethisterone; Ethinyl Estradiol; Female; Fertility; Fetal Death; Humans; Karyotyping; Medroxyprogesterone; Medroxyprogesterone Acetate; Mosaicism; Ovary; Pregnancy; Pregnancy Complications; Sterilization, Tubal; Turner Syndrome | 1985 |